These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8496271)

  • 1. Measurement of naloxone in plasma using high-performance liquid chromatography with electrochemical detection.
    Reid RW; Deakin A; Leehey DJ
    J Chromatogr; 1993 Apr; 614(1):117-22. PubMed ID: 8496271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of naloxone in blood by high-performance liquid chromatography.
    Asali LA; Nation RL; Brown KF
    J Chromatogr; 1983 Dec; 278(2):329-35. PubMed ID: 6668313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalmefene: quantitation of a new narcotic antagonist in human plasma using high performance-liquid chromatography with electrochemical detection.
    Hsiao J; Dixon R
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):449-54. PubMed ID: 6665302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of naloxone in human plasma by high-performance liquid chromatography with coulometric detection.
    Franklin M; Odontiadis J
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):199-203. PubMed ID: 8998562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of naltrexone and 6 beta-naltrexol in plasma by high-performance liquid chromatography with coulometric detection.
    Zuccaro P; Altieri I; Betto P; Pacifici R; Ricciarello G; Pini LA; Sternieri E; Pichini S
    J Chromatogr; 1991 Jul; 567(2):485-90. PubMed ID: 1939481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients.
    Kambia K; Bah S; Dine T; Azar R; Odou P; Gressier B; Luyckx M; Brunet C; Ballester L; Cazin M; Cazin JC
    Biomed Chromatogr; 2000 May; 14(3):151-5. PubMed ID: 10850617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrochemical chromatographic determinations of morphine antagonists in biological fluids, with applications.
    Derendorf H; El-Din A; El-Koussi A; Garrett ER
    J Pharm Sci; 1984 May; 73(5):621-4. PubMed ID: 6737235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and pharmacokinetic analysis of naloxone in plasma using high-performance liquid chromatography with electrochemical detection and solid-phase extraction.
    Albeck H; Woodfield S; Kreek MJ
    J Chromatogr; 1989 Mar; 488(2):435-45. PubMed ID: 2745633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic assay for mitoxantrone in plasma using electrochemical detection.
    Choi KE; Sinkule JA; Han DS; McGrath SC; Daly KM; Larson RA
    J Chromatogr; 1987 Sep; 420(1):81-8. PubMed ID: 3667832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and sensitive assay of dobutamine in plasma by high-performance liquid chromatography and electrochemical detection.
    Husseini H; Mitrovic V; Schlepper M
    J Chromatogr; 1993 Oct; 620(1):164-8. PubMed ID: 8106586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection.
    Davidson AF; Emm TA; Pieniaszek HJ
    J Pharm Biomed Anal; 1996 Sep; 14(12):1717-25. PubMed ID: 8887719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of buprenorphine in rat plasma using a solid-phase extraction technique and high-performance liquid chromatography with electrochemical detection.
    Salem A; Pierce TL; Hope W
    J Pharmacol Toxicol Methods; 1997 Mar; 37(2):75-81. PubMed ID: 9174982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma.
    Sun W; Qu S; Du Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():157-63. PubMed ID: 24566267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined liquid chromatography-coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients.
    Somaini L; Saracino MA; Marcheselli C; Zanchini S; Gerra G; Raggi MA
    Anal Chim Acta; 2011 Sep; 702(2):280-7. PubMed ID: 21839210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
    Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection.
    Catlow JT; Barton RD; Clemens M; Gillespie TA; Goodwin M; Swanson SP
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):85-90. PubMed ID: 7550985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous extraction and chromatographic analysis of morphine, dilaudid, naltrexone and naloxone in biological fluids by high-performance liquid chromatography with electrochemical detection.
    O'Connor EF; Cheng SW; North WG
    J Chromatogr; 1989 Jun; 491(1):240-7. PubMed ID: 2477388
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection.
    Stinson SF; Hill K; Siford TJ; Phillips LR; Daw TW
    Cancer Chemother Pharmacol; 1998; 42(4):261-5. PubMed ID: 9744769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple liquid chromatographic method for the determination of naltrexone in human plasma using amperometric detection.
    Peh KK; Billa N; Yuen KH
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):140-5. PubMed ID: 9389350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.